Peptide inhibitors of C3 breakdown.
We have investigated the development of substrate-based inhibitors of complement enzymes. Sequences around the scissile Arg77-Ser78 bond of C3 have been synthesized and tested as inhibitors of C3 convertase. The best inhibition was found with the tetrapeptide Ac-Arg-Ser-Asn-Leu-OH (H-576); extending this sequence in either direction reduced inhibitory activity. Preliminary experiments with peptides in which the scissile bond--CO--NH--was replaced with non-hydrolysable moieties such as--CO--CH2--(H-497) and--CH2--NH--(H-336) failed to show enhanced inhibition. One of the longer chain inhibitors H-416 containing DArg77-Ser78 was unexpectedly found to potentiate iC3 cleavage by factors I and H but did not inhibit the intact alternative pathway. The same peptide also bound to factor H. It is concluded that the binding requirements of the C3 convertase are more sophisticated than can be satisfactorily imitated simply by linear sequences around the scissile bond of C3.
Peake
P
P
Prince Henry Hospital, Little Bay, NSW, Australia.
Szelke
M
M
Jones
D M
DM
Singleton
A
A
Sueiras-Diaz
J
J
Lachmann
P J
PJ
D003166:Complement Activating Enzymes / Q000037:antagonists & inhibitors*; D003176:Complement C3 / Q000378:metabolism*; D050577:Complement C3-C5 Convertases / Q000037:antagonists & inhibitors*; D003180:Complement C3b Inactivator Proteins / Q000502:physiology; D017242:Complement Factor H; D009842:Oligopeptides / Q000494:pharmacology*
D003176:Complement C3; D003180:Complement C3b Inactivator Proteins; D009842:Oligopeptides; D017242:Complement Factor H; D003166:Complement Activating Enzymes; D050577:Complement C3-C5 Convertases